Activities at the Heidelberg Ion Therapy Center (HIT)
|
|
- Ginger Dean
- 6 years ago
- Views:
Transcription
1 Activities at the Heidelberg Ion Therapy Center (HIT) The people A. Mairani (now INFN), F. Sommerer (Uniklinikum Heidelberg), I. Rinaldi (DKFZ Heidelberg), K. Parodi (HIT and University of Heidelberg) Still 1 open postdoc position for FLUKA simulations for PET
2 The Heidelberg Ion Therapy Center (HIT) Low-LET modality: Protons (later also He) High-LET modality: Carbon (later also Oxygen) Start of clinical operation: 15 th November 2009 Based on more than 10 years of experience at GSI Compact design 2 ion sources for different ion selection within minutes Heavy ion synchrotron 3 Treatment rooms 2 horizontal, fixed beam 1 isocentric ion gantry 1 QA / exp. cave
3 The role of MC at HIT Treatment planning system at HIT: first CE labeled ion TPS system (Syngo PT Planning, Siemens) based on pencil beam algorithms Application of MC at HIT to support: Startup and Commissioning: Generation of accelerator beam library ( LIBC ) and TPS input data ( meas. time) Validation of TPS dose calculations: in water equivalent system and in patient anatomy (CT) Dedicated Quality Assurance: imaging of emerging radiation for treatment verification (PET, prompt )
4 Why using FLUKA? Protons (183 MeV/u) in water 12 C ions (400 MeV/u) in water Exp. Data (points) taken at HIT: D. Schardt, P. Steidl, K. Parodi, S. Brons; FLUKA simulation: K. Parodi Exp. Data (points) taken at GSI: Haettner et al, Rad. Prot. Dos FLUKA simulation: A. Mairani (published in Il Nuovo Cimento )
5 Mixed Radiation Field in Carbon Ion therapy 12 C ions (400 MeV/u) on Water phantoms Carbon Beam Attenuation Build-up of secondary fragments Exp. Data (POINTS) FLUKA (LINES) Exp. Data (STARS) FLUKA (POINTS with lines) Exp. Data from Haettner et al, Rad. Prot. Dos MC simulations from A. Mairani, PhD Thesis 2007, A. Mairani et al to be published
6 MC for the Heidelberg Ion Therapy Center (HIT) To be published Ion species p, 12 C (later also 3 He, 16 O) Beam delivery Scanning with active energy variation GSI) Required parameters: 255 Energy steps 4 Foci 10 Intensities Focus (FWHM) in Isocentre (mm) 12 HIT (Nominal focus from FLUKA b) Energy (MeV/u) Taking into account desired 4 10 mm ISO for higher E and physical limitation from scattering in monitor system and air HIT, Heidelberg, Germany
7 MC for the Heidelberg Ion Therapy Center (HIT) Generation of basic input data for TPS FLUKA calculation of depth dose profiles in water w/wo ripple filter (RiFi) for all the 255 energies delivered by accelerator for p and 12 C HIT 12 C + 3mm HIT Dose (MC: MeVcm 2 /g; Meas. Norm. to area) Dose (MC: MeVcm 2 /g; Meas. Norm. to area) Depth (cm) Parodi, Mairani et al to be published Depth (cm)
8 MC for the Heidelberg Ion Therapy Center (HIT) FLUKA dose calculations of irradiated fields for comparison with measurements and TPS calculation to support TPS commissioning Meas.: ICs in water phantom + data acquisition system from C. Karger (DKFZ) Beam eye view Along depth Along depth FLUKA: ~ 10 8 p out of irradiated Parodi, Mairani, Brons, Sommerer, HIT
9 From dose in water to dose in patient CT FLUKA CT based calculations: formalism originally developed for proton passive delivery at MGH for PET/CT post treatment verification XiO TPS MC dose MC PET PET/CT Meas. Field 2 Field 1 mgy mgy Bq/ml Bq/ml Parodi et al., IJROBP extended to scanned proton and carbon ion beam delivery, including biological dose modeling
10 MC for biological dose GSI / HIT FLUKA interfaced during runtime with the Local-Effect-Model (M. Scholz et al, GSI) used by GSI / HIT Validation for two opposing fields with H shaped target TPS (TRiP98): biological planning and optimization for CHO cells FLUKA LEM: forward calculation of the optimized plan FLUKA TRiP98 Exp data Exp. Data and analytical calculations: Krämer et al, PMB 48 (2003) 2063 MC Calculations: A. Mairani et al, Poster P104 Exp. Data and TPS calculations: Krämer et al, PMB 48 (2003) 2063 MC Calculations: A. Mairani et al, to be submitted
11 A. Mairani et al IEEE CR 2008, A. Mairani et al, to be published FLUKA MC versus TPS for carbon ion GSI Clivus Chordoma Patient Absorbed/Biological Dose mgy FLUKA - LEM mgye TRiP mgy TRiP mgye
12 Ongoing activities Summary and Outlook - Adaptation of work done for MGH Boston and GSI to HIT for clinical CTbased recalculation of treatment plans (Florian) - Standard and novel imaging techniques for in-vivo dose verification (Ilaria) Relevant achievements so far - PMB paper Sommerer et al (on his PhD work) was selected as featured paper, 250 times download in the first 6 weeks (advertised on Medicalphysicsweb) Awards in the last year - Schmelzer Preis for A. Mairani PhD Thesis (Darmstadt, 01/2010) - IEEE Medical Imaging Young Investigator for K. Parodi (Orlando, 10/2009 Future activities of possible general interest - EU project ENVISION for MC application to PET (HIT, CERN, INFN) - Validation of FLUKA models for helium and oxygen beams
13 (Intensity modulated raster scan, 12 C at 430 Mev/u, October 15 th 2007)
Proton and helium beams: the present and the future of light ion beam therapy
Proton and helium beams: the present and the future of light ion beam therapy Dr. Andrea Mairani Group Leader Biophysics in Particle Therapy Heidelberg Ion Beam Therapy Center HIT Department of Radiation
More informationThe Heidelberg Ion Therapy Center and PARTNER. Thomas Haberer Heidelberg Ion Therapy Center
The Heidelberg Ion Therapy Center and PARTNER Thomas Haberer Heidelberg Ion Therapy Center Goal The key element to improve the clinical outcome is local control! entrance channel: low physical dose low
More informationProf. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center
The Heidelberg Ion Beam Therapy Center A Hospital-based Facility Dedicated to Precision and Flexibility Prof. Dr. Thomas Haberer Scientific-technical Director Heidelberg Iontherapy Center Carbon Ion Therapy
More informationIN VIVO IMAGING Proton Beam Range Verification With PET/CT
IN VIVO IMAGING Proton Beam Range Verification With PET/CT Antje-Christin Knopf 1/3 K Parodi 2, H Paganetti 1, T Bortfeld 1 Siemens Medical Solutions Supports This Project 1 Department of Radiation Oncology,
More informationThe Heidelberg Ion Therapy (HIT) Accelerator Coming Into Operation. Presented at EPAC 2008, Genova D. Ondreka, GSI
The Heidelberg Ion Therapy (HIT) Accelerator Coming Into Operation Presented at EPAC 2008, Genova D. Ondreka, GSI Introduction Heidelberg Ion Therapy Centre: Europe's first dedicated particle therapy facility
More informationBiological Optimization of Hadrontherapy. Uwe Oelfke
4/2/2012 page 1 Biological Optimization of Hadrontherapy Uwe Oelfke DKFZ Heidelberg (E040) Im Neuenheimer Feld 280 69120 Heidelberg, Germany u.oelfke@dkfz.de 4/2/2012 page 2 Contents Introduction and General
More informationThe Heidelberg Ion Therapy Center. Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009
The Heidelberg Ion Therapy Center Thomas Haberer Heidelberg Ion Therapy Center Hadron Therapy Workshop, Erice 2009 Goal The key element to improve the clinical outcome is local l control! entrance channel:
More informationThe Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center
The Advantages of Particle Therapy and the Status of the Heidelberg Iontherapy Center Thomas Haberer, Scientific Technical Director, Heidelberg Ion Therapy Center Situation / Indications 2/3 patients suffer
More informationQuality Assurance beam tracking Nami Saito GSI, Darmstadt, Germany biophysics department
Quality Assurance beam tracking Nami Saito GSI, Darmstadt, Germany biophysics department 1 Oct 2009 N. Saito PTCOG 48 Heidelberg 1 Introduction Beam tracking GSI beam tracking system Beam tracking QA Function
More informationNuclear Data for Radiation Therapy
Symposium on Nuclear Data 2004 Nov. 12, 2004 @ JAERI, Tokai Nuclear Data for Radiation Therapy ~from macroscopic to microscopic~ Naruhiro Matsufuji, Yuki Kase and Tatsuaki Kanai National Institute of Radiological
More informationClinical Results of Carbon Ion Radiotherapy: The Heidelberg Experience
Clinical Results of Carbon Ion Radiotherapy: The Heidelberg Experience Stephanie E. Combs, MD Department of Radiation Oncology University of Heidelberg, Germany Carbon ion RT at GSI Active beam delivery
More informationIMPT with Carbon Ions
IMPT with Carbon Ions PTCOG 48, Heidelberg, 28.09.-03.10.2009 Malte Ellerbrock Medical Physics Expert Heidelberg Ion-Beam Therapy Center HIT Betriebs GmbH am Universitätsklinikum Heidelberg http://www.hit-centrum.de
More informationHeavy Ion Tumor Therapy
Heavy Ion Tumor Therapy Applications Bence Mitlasoczki 25.06.2018 Heidelberg 1. Source (H 2 /CO 2 ) 2. Linac 3. Synchrotron 4. Guide 5. Treatment rooms 6. X-ray system 7. Gantry 8. Treatment room with
More informationWorkshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May
IONTRIS Synchrotron based PT Solutions from Siemens AG Workshop on Hadron Beam Therapy of Cancer Erice, Sicily April 24-May 1 2009 Matthias Herforth VP Business Development and Communications Siemens AG
More informationIII. Proton-therapytherapy. Rome SB - 5/5 1
Outline Introduction: an historical review I Applications in medical diagnostics Particle accelerators for medicine Applications in conventional radiation therapy II III IV Hadrontherapy, the frontier
More informationHampton University Proton Therapy Institute
Hampton University Proton Therapy Institute Brief introduction to proton therapy technology, its advances and Hampton University Proton Therapy Institute Vahagn Nazaryan, Ph.D. Executive Director, HUPTI
More informationImage Guided Proton Therapy and Treatment Adaptation
Image Guided Proton Therapy and Treatment Adaptation www.hollandptc.nl d.r.schaart@tudelft.nl Cancer in The Netherlands About 1 in 3 people get cancer in some stage of their life 86.800 new cancer patients
More informationTopics covered 7/21/2014. Radiation Dosimetry for Proton Therapy
Radiation Dosimetry for Proton Therapy Narayan Sahoo Department of Radiation Physics University of Texas MD Anderson Cancer Center Proton Therapy Center Houston, USA Topics covered Detectors used for to
More informationRadiation qualities in carbon-ion radiotherapy at NIRS/HIMAC
Radiation qualities in carbon-ion radiotherapy at NIRS/ Shunsuke YONAI Radiological Protection Section Research Center for Charged Particle Therapy National Institute of Radiological Sciences (NIRS) E-mail:
More informationTumor Therapy with Heavy Ions at GSI Darmstadt
Tumor Therapy with Heavy Ions at GSI Darmstadt D. Schardt 1) for the Heavy Ion Therapy Collaboration 2) 1) Gesellschaft für Schwerionenforschung (GSI), Darmstadt, Germany 2) GSI Darmstadt / Radiologische
More informationProton and heavy ion radiotherapy: Effect of LET
Proton and heavy ion radiotherapy: Effect of LET As a low LET particle traverses a DNA molecule, ionizations are far apart and double strand breaks are rare With high LET particles, ionizations are closer
More informationNew Treatment Research Facility Project at HIMAC
New Treatment Research Facility Project at Koji Noda Research Center for Charged Particle Therapy National Institute of Radiological Sciences IPAC10, Kyoto, JAPAN, 25th May, 2010 Contents 1. Introduction
More informationPROGRESS IN HADRONTHERAPY
PROGRESS IN HADRONTHERAPY Saverio Braccini TERA Foundation for Oncological Hadrontherapy IPRD06 - Siena - 01.10.06 - SB 1 Outline Introduction Radiation therapy with X rays and hadrontherapy Hadrontherapy
More informationOverview. Proton Therapy in lung cancer 8/3/2016 IMPLEMENTATION OF PBS PROTON THERAPY TREATMENT FOR FREE BREATHING LUNG CANCER PATIENTS
IMPLEMENTATION OF PBS PROTON THERAPY TREATMENT FOR FREE BREATHING LUNG CANCER PATIENTS Heng Li, PhD Assistant Professor, Department of Radiation Physics, UT MD Anderson Cancer Center, Houston, TX, 773
More informationSCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY
SCIENTIFIC AND TECHNOLOGICAL DEVELOPMENT OF HADRONTHERAPY SAVERIO BRACCINI * Albert Einstein Centre for Fundamental Physics, Laboratory for High Energy Physics (LHEP), University of Bern, Sidlerstrasse
More informationReview of Heavy Ion Accelerators for Hadrontherapy
Review of Heavy Ion Accelerators for Hadrontherapy Koji Noda Research Center for Charged Particle Therapy National Institute of Radiological Sciences 11 th Int l Conf. on Heavy Ion Accelerator Technology,
More informationRecent advances in dosimetry in reference conditions for proton and light-ion beams
Recent advances in dosimetry in reference conditions for proton and light-ion beams S. Vatnitskiy a), P. Andreo b) and D.T.L. Jones c) a) MedAustron, Wiener Neustadt, Austria b) Medical Radiation Physics,
More informationCancer Treatment by Charged Particles - Carbon Ion Radiotherapy -
Cancer Treatment by Charged Particles - Carbon Ion Radiotherapy - Takeshi Murakami Research Center of Charged Particle Therapy National Institute of Radiological Sciences 2012.11.21 1. Introduction to
More informationCharacterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning
Characterization and implementation of Pencil Beam Scanning proton therapy techniques: from spot scanning to continuous scanning Supervisors Prof. V. Patera PhD R. Van Roermund Candidate Annalisa Patriarca
More informationEfficient Dosimetry for Proton Therapy
Efficient Dosimetry for Proton Therapy Why IBA Dosimetry? IBA Dosimetry offers the full product range tailored to fit any Proton Therapy QA needs. PT treatment safety, as well as most efficient dosimetry
More informationOPERATION AND PATIENT TREATMENTS AT CNAO FACILITY
OPERATION AND PATIENT TREATMENTS AT CNAO FACILITY Abstract The CNAO (National Centre for Oncological Hadrontherapy) has been realized in Pavia. It is a clinical facility created and financed by the Italian
More informationHeavy Ion Therapy: Status and Perspectives
Technology in Cancer Research & Treatment ISSN 1533-0346 Volume 2, Number 5, October (2003) Adenine Press (2003) Heavy Ion Therapy: Status and Perspectives www.tcrt.org Starting with the pioneering work
More informationAnalytical Methods for Normal- Tissue Dose Reconstructions. Acknowledgments. Disclosures. Learning Objectives 8/2/2017. Wayne Newhauser, PhD
Analytical Methods for Normal- Tissue Dose Reconstructions Wayne Newhauser, PhD newhauser@lsu.edu AAPM Annual Meeting, August 2, 2017 Acknowledgments Bella Bowman Foundation Numerous current and former
More informationReview of Hadron machines for cancer therapy
Review of Hadron machines for cancer therapy M. Kanazawa NIRS cancer therapy with hadron (p, C) Clinical studies at New ideas of accelerators Compact facilities (p, C) Depth dose distribution Carbon, proton
More informationOut-of-field dosimetry in radiotherapy for input to epidemiological studies. Roger Harrison
MELODI 7th Workshop, 9 11 November 2015 Helmholtz Zentrum München Next Generation Radiation Protection Research Out-of-field dosimetry in radiotherapy for input to epidemiological studies Roger Harrison
More informationHeidelberg Ion-Beam Therapy Centre (HIT) officially opened
Powered by Website address: https://www.gesundheitsindustrie-bw.de/en/article/pressrelease/heidelberg-ion-beam-therapy-centre-hit-officiallyopened/ Heidelberg Ion-Beam Therapy Centre (HIT) officially opened
More informationFIRST PATIENTS TREATMENT AT GSI USING HEAVY-ION BEAMS
FIRST PATIENTS TREATMENT AT GSI USING HEAVY-ION BEAMS G. Kraft, E. Badura, W. Becher, D. Böhne, H. Brand, C. Brusasco, H. Eickhoff, H.G. Essel, B. Franzcak. O. Geiß, Th. Haberer. J. Hoffmann, P. Kainsberger,
More informationSUMITOMO Particle Therapy Technologies
55 th AAPM annual meeting Particle Beam Therapy Symposium SUMITOMO Particle Therapy Technologies August 3, 2013 Yukio Kumata Experience accelerators for science Current Status proton and carbon Future
More informationA fast Monte Carlo toolkit on GPU for treatment plan dose recalculation in proton therapy
A fast Monte Carlo toolkit on GPU for treatment plan dose recalculation in proton therapy Martina Senzacqua PhD student in Accelerator Physics at University of Rome La Sapienza Department of Basic and
More informationIntroduction of RapidArc TM : an example of commissioning and implementing a QA programme for a new technology
Introduction of RapidArc TM : an example of commissioning and implementing a QA programme for a new technology Philip Mayles Clatterbridge Centre for Oncology, Wirral, UK 1 What is RapidArc (or VMAT)?
More informationProton Treatment. Keith Brown, Ph.D., CHP. Associate Director, Radiation Safety University of Pennsylvania
Proton Treatment Keith Brown, Ph.D., CHP Associate Director, Radiation Safety University of Pennsylvania Proton Dose vs. Depth Wilson,. R.R. Radiological use of fast protons. Radiology 47:487-491, 1946.
More informationLearning Objectives. Clinically operating proton therapy facilities. Overview of Quality Assurance in Proton Therapy. Omar Zeidan
Overview of Quality Assurance in Proton Therapy Omar Zeidan AAPM 2012 Charlotte, NC July 30 st, 2012 Learning Objectives Understand proton beam dosimetry characteristics and compare them to photon beams
More informationProton Beam Therapy at Mayo Clinic
Proton Beam Therapy at Mayo Clinic Jon J. Kruse, Ph.D. Mayo Clinic Dept. of Radiation Oncology Rochester, MN History of Proton Therapy at Mayo 2002: Decided to consider particle therapy analysis and education
More informationYour co-operation partner for research. EUROPEAN UNION European Regional Development Fund
Med Austron Research Your co-operation partner for research EUROPEAN UNION European Regional Development Fund MedAustron MedAustron offers protons and carbon ions for therapy and research. With MedAustron,
More informationIon Beam Therapy should we prioritise research on helium beams?
Ion Beam Therapy should we prioritise research on helium beams? Stuart Green Medical Physics University Hospital Birmingham NHS Trust Follow-up from the EUCARD2 workshop, ION Beam Therapy: Clinical, Scientific
More informationFuture upcoming technologies and what audit needs to address
Future upcoming technologies and what audit needs to address Dr R.I MacKay History of audit Absolute dose - Simple phantom standard dose measurement Point doses in beams - Phantoms of relatively simple
More informationMEDICAL PHYSICS ASPECTS OF PARTICLE THERAPY Oliver Jäkel 1,2, *
Radiation Protection Dosimetry (2009), Vol. 137, No. 1 2, pp. 156 166 Advance Access publication 14 October 2009 doi:10.1093/rpd/ncp192 MEDICAL PHYSICS ASPECTS OF PARTICLE THERAPY Oliver Jäkel 1,2, * 1
More informationCan we hit the target? Can we put the dose where we want it? Quality Assurance in Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy
Quality Assurance in Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy David Shepard, Ph.D. Swedish Cancer Institute Seattle, WA Timothy D. Solberg, Ph.D. University of Texas Southwestern
More informationA brief presentation of The TERA Foundation
A brief presentation of The TERA Foundation David Watts on behalf of Prof. Ugo Amaldi and all my colleagues at TERA TERA Overview Direction: Prof. Ugo Amaldi AQUA (Advanced QUAlity Assurance) Cyclinac
More informationImage based in-vivo dosimetry: from PET to in-beam SPECT
Image based in-vivo dosimetry: from PET to in-beam SPECT 2nd Workshop on Hadron Beam Therapy of Cancer Erice, Sicily, Italy May 25th, 2011 Fine Fiedler Institute of Radiation Physics Text optional: Institutsname
More information8/3/2016. Clinical Significance of RBE Variations in Proton Therapy. Why RBE (relative biological effectiveness)?
8//06 Clinical Significance of Variations in Proton Therapy H. Paganetti PhD Professor, Harvard Medical School Director of Physics Research, Massachusetts General Hospital, Radiation Oncology Introduction
More informationAn anthropomorphic head phantom with a BANG polymer gel insert for dosimetric evaluation of IMRT treatment delivery
An anthropomorphic head phantom with a BANG polymer gel insert for dosimetric evaluation of IMRT treatment delivery G. Ibbott a, M. Beach a, M. Maryanski b a M.D. Anderson Cancer Center, Houston, Texas,
More informationA review of cyclotrons for Hadron Therapy. Y. Jongen Cyclotrons 2010 Lanzhou, September
A review of cyclotrons for Hadron Therapy Y. Jongen Cyclotrons 2010 Lanzhou, September 10 2010 The early days The possible use of the Bragg peak of high energy ions in the radiotherapy of cancer was suggested
More informationRadiobiology for particle therapy
Radiobiology for particle therapy Marco Durante CNAO-NIRS meeting, Pavia 21.03.2010 INFN Workshop, Napoli, 4.4.2014 2 The radiobiological adavantages of particle therapy Jakob et al., PNAS 2009 PIDE database
More informationFROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE. Geoffrey S. Ibbott, Ph.D. June 20, 2017
FROM ICARO1 TO ICARO2: THE MEDICAL PHYSICS PERSPECTIVE Geoffrey S. Ibbott, Ph.D. June 20, 2017 1 DISCLOSURES My institution holds Strategic Partnership Research Agreements with Varian, Elekta, and Philips
More informationMAESTRO: Methods and Advanced Equipment for Simulation and Treatment in Radiation Oncology
What is MAESTRO? Sixth Framework Program FP6 (2002-2006) European Commission Integrated Project Duration: 5 years MAESTRO: Methods and Advanced Equipment for Simulation and Treatment in Radiation Oncology
More informationProgress of Heavy Ion Therapy
Progress of Heavy Ion Therapy Fuminori Soga Division of Accelerator Physics and Engineering, National Institute of Radiological Sciences, 4-9-1 Anagawa. Inage-ku, Chiba 263-8555, Japan 1. Introduction
More informationAssessing Heterogeneity Correction Algorithms Using the Radiological Physics Center Anthropomorphic Thorax Phantom
Assessing Heterogeneity Correction Algorithms Using the Radiological Physics Center Anthropomorphic Thorax Phantom David Followill, Ph.D. Associate Director Radiological Physics Center RPC History Lesson
More informationSpecifics of treatment planning for active scanning and IMPT
Specifics of treatment planning for active scanning and IMPT SFUD IMPT Tony Lomax, Centre for Proton Radiotherapy, Paul Scherrer Institute, Switzerland Treatment planning for scanning 1. Single Field,
More informationAdopting DAP as a dose metric in CT
Adopting DAP as a dose metric in CT Nick Weir Department of Medical Physics Royal Infirmary of Edinburgh NHS Lothian Dose Area Product (DAP) in CT Hypothesis: There are advantages to using DAP: (i) In
More informationProtons Monte Carlo water-equivalence study of two PRESAGE formulations for proton beam dosimetry J. Phys.: Conf. Ser.
Protons Monte Carlo water-equivalence study of two PRESAGE formulations for proton beam dosimetry T Gorjiara, Z Kuncic, J Adamovics and C Baldock 2013 J. Phys.: Conf. Ser. 444 012090 PRESAGE is a radiochromic
More informationSBRT Credentialing: Understanding the Process from Inquiry to Approval
SBRT Credentialing: Understanding the Process from Inquiry to Approval David Followill, Ph.D. (presented by Andrea Molineu, M.S.) IROC Houston QA Center July 15, 2015 What is credentialing? Verification
More informationParticle Therapy Systems by Mitsubishi Electric DG1101-KM-0034
Particle Therapy Systems by Mitsubishi Electric DG1101-KM-0034 Saudi-Japan Business Opportunities Forum February 1 2, 2012 1 2 Types of Treatment Conventional Radiation Therapy Uses photons (energetic
More informationThe RPC s Evaluation of Advanced Technologies. AAPM Refresher Course July 29, 2008 Geoffrey S. Ibbott, Ph.D. and RPC Staff
The RPC s Evaluation of Advanced Technologies AAPM Refresher Course July 29, 2008 Geoffrey S. Ibbott, Ph.D. and RPC Staff 1 http://rpc.mdanderson.org Supported by: NCI grants CA10953 and CA81647, and an
More informationApplication of Implanted Markers in Proton Therapy. Course Outline. McLaren Proton Therapy Center Karmanos Cancer Institute McLaren - Flint
Application of Implanted Markers in Proton Therapy Sung Yong Park, Ph.D. McLaren Proton Therapy Center Karmanos Cancer Institute McLaren - Flint AAPM 2016, SAM Therapy Educational Course, 2016.08.04. Course
More informationNuclear Physics in Proton Radiotherapy
Nuclear Physics in Proton Radiotherapy Cynthia Keppel, PhD Thomas Jefferson National Accelerator Facility (Hampton University Proton Therapy institute) International Nuclear Physics Conference Adelaide,
More informationQuality Assurance of TPS: comparison of dose calculation for stereotactic patients in Eclipse and iplan RT Dose
Petrovic B Comparison of dose calculation algorithms for stereotaxy Quality Assurance of TPS: comparison of dose calculation for stereotactic patients in and RT Dose Borislava Petrovic 1, Aleksandra Grządziel
More informationFuture Proton Irradiation Facility at OncoRay
Future Proton Irradiation Facility at OncoRay Seminar am Institut für Kern- und Teilchenphysik Technische Universität Dresden 14. Juli 2011 Wolfgang Enghardt OncoRay National Center for Radiation Research
More informationHADRONTHERAPY: a new frontier for cancer treatment
Razionale HADRONTHERAPY: a new frontier for cancer treatment September, 19 20 2014 Hadrontherapy is a specific type of localized radiation therapy, which uses fast hadrons (charged particles made of quarks)
More informationD DAVID PUBLISHING. Uncertainties of in vivo Dosimetry Using Semiconductors. I. Introduction. 2. Methodology
Journal of Life Sciences 9 (2015) 120-126 doi: 10.17265/1934-7391/2015.03.005 D DAVID PUBLISHING Uncertainties of in vivo Dosimetry Using Semiconductors Zeina Al Kattar, Hanna El Balaa and Saeed Zahran
More informationStatus of Hadrontherapy facilities worldwide
Status of Hadrontherapy facilities worldwide Vienna 15.03.2011 The Gantry 1 of PSI Eros Pedroni Center for Proton Radiation Therapy Paul Scherrer Institute SWITZERLAND Author s competence: Gantry with
More informationState-of-the-art proton therapy: The physicist s perspective
State-of-the-art proton therapy: Tony Lomax, Centre for Proton Radiotherapy, Paul Scherrer Institute, Switzerland Overview of presentation 1. State-of-the-art proton delivery 2. Current challenges 3. New
More informationCalculated LET spectrum from antiproton beams stopping in water
Acta Oncologica, 2009; 48: 223226 ORIGINAL ARTICLE Calculated LET spectrum from antiproton beams stopping in water NIELS BASSLER 1,2 & MICHAEL HOLZSCHEITER 3 1 Department of Experimental Clinical Oncology,
More informationAssessment of Dosimetric Functions of An Equinox 100 Telecobalt Machine
2017 IJSRST Volume 3 Issue 3 Print ISSN: 2395-6011 Online ISSN: 2395-602X Themed Section: Science and Technology Assessment of Dosimetric Functions of An Equinox 100 Telecobalt Machine Samuel Nii Adu Tagoe
More informationClinical Impact of Couch Top and Rails on IMRT and Arc Therapy
Texas Medical Center Library DigitalCommons@TMC UT GSBS Dissertations and Theses (Open Access) Graduate School of Biomedical Sciences 8-2011 Clinical Impact of Couch Top and Rails on IMRT and Arc Therapy
More informationNUCLEAR PHYSICS FOR MEDICINE - HADRON THERAPY. Pawel Olko Institute of Nuclear Physics Krakow Poland
NUCLEAR PHYSICS FOR MEDICINE - HADRON THERAPY Pawel Olko Institute of Nuclear Physics Krakow Poland The NuPECC report: Nuclear Physics in Medicine http://www.nupecc.org/pub/npmed2014.pdf Outline 1. Why
More informationVenue: IEEE NSS/MIC/RTSD Conference, Seoul, South Korea, 27 th October 2013 Workshop: NWK3/RD1 Radiation Protection and Dosimetry
Venue: IEEE NSS/MIC/RTSD Conference, Seoul, South Korea, 27 th October 2013 Workshop: NWK3/RD1 Radiation Protection and Dosimetry M. Caresana a, A. Sashala Naik a,c, S. Rollet b, M. Ferrarini a,d a Polytechnic
More informationPredicting the risk of developing a radiationinduced second cancer when treating a primary cancer with radiation
Remaining physics challenges in proton therapy Predicting the risk of developing a radiationinduced second cancer when treating a primary cancer with radiation H. Paganetti PhD Professor and Director of
More informationDigital film dosimetry in radiotherapy and the development of analytical applications software
University of Wollongong Research Online University of Wollongong Thesis Collection 1954-2016 University of Wollongong Thesis Collections 2005 Digital film dosimetry in radiotherapy and the development
More informationCOMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE
COMPARISON OF RADIOBIOLOGICAL EFFECTS OF CARBON IONS TO PROTONS ON A RESISTANT HUMAN MELANOMA CELL LINE I. Petrovi a, A. Risti -Fira a, L. Kori anac a, J. Požega a, F. Di Rosa b, P. Cirrone b and G. Cuttone
More informationAre Transmission Detectors a Necessary Tool for a Safe Patient Radiation Therapy Program?
Are Transmission Detectors a Necessary Tool for a Safe Patient Radiation Therapy Program? Can you currently use direct documentation and measurement of delivered dose to ensure you did not underdose or
More informationData Collected During Audits for Clinical Trials. July 21, 2010 Geoffrey S. Ibbott, Ph.D. and RPC Staff
Data Collected During Audits for Clinical Trials July 21, 2010 Geoffrey S. Ibbott, Ph.D. and RPC Staff RPC Programs Assure... Constancy of basic machine calibration (TLD/OSLD Audits) Validity of treatment
More informationParticle Therapy- Why?
Particle Therapy- Why? Kill tumour without affecting healthy cells X-Ray Therapy Head, neck, Spinal cord Eyes, orbits Pelvis Prostate Lung PEDIATRIC Proton Therapy Photon IMRT Photon Proton (Courtesy of
More informationAbstract: A National Project for the in-vivo dosimetry in radiotherapy: first results
Abstract: A National Project for the in-vivo dosimetry in radiotherapy: first results A.Piermattei 1, L. Azario 1, S. Cilla 2, A.Fidanzio 1, F.Greco 1, M.T.Russo 3, S. Zucca 4 1 Istituto di Fisica e Unità
More informationRadiation treatment planning in lung cancer
Radiation treatment planning in lung cancer Georg Dietmar 1,2 1 Div. Medical Rad. Phys., Dept. of Radiation Oncology / Medical Univ. Vienna & AKH Wien 2 Christian Doppler Laboratory for Medical Radiation
More informationIntegration of PT in an existing radiation oncology center
Integration of PT in an existing radiation oncology center Tom Depuydt, PhD Head of medical Physics, Radiation Oncology UZ Leuven-KU Leuven and ParTICLe proton therapy project tom.depuydt@uzleuven.be 1
More informationLa ricerca e la terapia in adroterapia-2. R.Orecchia / P. Fossati
La ricerca e la terapia in adroterapia-2 R.Orecchia / P. Fossati Dose (Gy) = energy (joule) / mass (kg) One degree of fever (from 37.5 to 38.5 ) > 4000 Gy RT small dose big damage Photons : Dose Resposne
More informationVarian Edge Experience. Jinkoo Kim, Ph.D Henry Ford Health System
Varian Edge Experience Jinkoo Kim, Ph.D Henry Ford Health System Disclosures I participate in research funded by Varian Medical Systems. Outline of Presentation Review advanced imaging in Varian Edge Linear
More informationCERN: from particle physics to medical applications. Manuela Cirilli CERN Knowledge Transfer Life Sciences Section
CERN: from particle physics to medical applications Manuela Cirilli CERN Knowledge Transfer Life Sciences Section The mission of CERN Research Innovation Push forward the frontiers of knowledge Develop
More informationAspects of Industrialization of Accelerators for Particle Therapy ICABU, November 11, 2013, Daejeon
Aspects of Industrialization of Accelerators for Particle Therapy ICABU, November 11, 2013, Daejeon Introduction Why Particle Therapy? PT Milestones What is meant by Industrialization Examples Protons-only:
More informationQuality assurance in external radiotherapy
Quality assurance in external radiotherapy dr. Marius Laurikaitis medical physicist Oncological Hospital of Kaunas Medical University Hospital Kaunas, 2010-10-14 Acceptance and Commissioning Acceptance
More informationDr. Robert R. Wilson, a physicist who had worked on
Radiation Therapy With Charged Particles Daniela Schulz-Ertner, MD,* Oliver Jäkel, PhD, and Wolfgang Schlegel, PhD Charged particle beams can offer an improved dose conformation to the target volume as
More informationDependence of the thermoluminescent high-temperature ratio (HTR) of LiF:Mg,Ti detectors on proton energy and dose
Submitted to Radiation Measurements Dependence of the thermoluminescent high-temperature ratio (HTR) of LiF:Mg,Ti detectors on proton energy and dose P. Bilski 1, M. Sadel 1, J. Swakon 1, A. Weber 2 1
More informationACCELERATORS FOR HADRONTHERAPY
ACCELERATORS FOR HADRONTHERAPY Alberto Degiovanni CERN-BE IVICFA s Fridays: Medical Physics Valencia, 31.10.2014 Introduction: the icon of hadrontherapy Position of the Bragg peak depends on beam energy
More informationProton Therapy Market Outlook - Global Analysis
Proton Therapy Market Outlook - Global Analysis Proton Therapy Market Outlook - Global Analysis BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen
More informationQuality assurance of volumetric modulated arc therapy using Elekta Synergy
Acta Oncologica, 2009; 48: 11931197 ORIGINAL ARTICLE Quality assurance of volumetric modulated arc therapy using Elekta Synergy AKIHIRO HAGA 1, KEIICHI NAKAGAWA 1, KENSHIRO SHIRAISHI 1, SAORI ITOH 1, ATSURO
More informationTumortherapy with ion beams
Nuclear Instruments and Methods in Physics Research A 454 (2000) 1}10 Tumortherapy with ion beams G. Kraft* For the Heavy Ion Therapy collaboration GSI Biophysik, Planckstrasse 1, 64291 Darmstadt, Germany
More informationA. DeWerd. Michael Kissick. Larry. Editors. The Phantoms of Medical. and Health Physics. Devices for Research and Development.
Larry Editors A. DeWerd Michael Kissick The Phantoms of Medical and Health Physics Devices for Research and Development ^ Springer Contents 1 Introduction to Phantoms of Medical and Health Physics 1 1.1
More informationPoland Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022
Poland Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton Therapy Centers and Forecast to 2022 Poland Proton Therapy Market (Actual & Potential), Patients Treated, List of Proton
More information